CME Group Inc. Stock
CME Group Inc. Stock
The CME Group Inc. stock is trending slightly upwards today, with an increase of €0.75 (0.320%) compared to yesterday's price.
Currently there is a rather positive sentiment for CME Group Inc. with 22 Buy predictions and 9 Sell predictions.
As a result the target price of 258 € shows a slightly positive potential of 10.4% compared to the current price of 233.7 € for CME Group Inc..
For the coming years our community has positive and negative things to say abot the CME Group Inc. stock. Criterium "EBIT growth" gathered the most positive votes but regarding "Expected dividend yield" there were negative voices in the community.
Pros and Cons of CME Group Inc. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of CME Group Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| CME Group Inc. | 0.320% | 0.581% | -1.455% | 2.142% | 5.508% | 43.269% | 58.076% |
| MarketAxess Holdings | 0.680% | 1.702% | 10.684% | -29.524% | -28.486% | -40.277% | -66.894% |
| Nasdaq OMX Group Inc. | 0.470% | 5.094% | 9.222% | 11.016% | 11.090% | 46.709% | 137.679% |
| Intercontinental Exchange Inc. | -0.040% | 0.807% | 2.416% | -4.796% | -3.742% | 43.787% | 49.304% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-04-18
Upon first examination of the financial statements for CME Group (ticker: CME), a company from the Investment Banking and Investment Services industry, it appears that the company maintains a solid financial foundation. It is evident that the company has experienced substantial growth over the years, expanding in key financial areas such as assets, revenues, and net income.
*Pros: *
Growth in total assets: CME Group has consistently grown its total assets from 124.6 billion USD in 2020 to 174.1 billion USD in 2022. The growth is driven by both current and non-current assets. The increase in current assets can signal an enhanced liquidity position for the company.
Comments
CME Group (NASDAQ:CME) had its "overweight" rating reaffirmed by analysts at Morgan Stanley. They now have a $320.00 price target on the stock.
Show more
Ratings data for CME provided by MarketBeat
CME Group (NASDAQ:CME) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $310.00 to $318.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CME provided by MarketBeat
CME Group (NASDAQ:CME) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $264.00 to $263.00. They now have a "sell" rating on the stock.
Show more
Ratings data for CME provided by MarketBeat